Email Us

Individualized Medication Guidance for Gastrointestinal Cancer CapitalBio

This test detects 84 genes related to gastrointestinal cancer, provides information on targeted drug、chemotherapy、 and hereditary risk assessment.


individualized medication guidance for gastrointes

Features of Individualized Medication Guidance for Gastrointestinal Cancer

Targeted drug

  • Gastrointestinal targeted drug gene loci and related pathway genes.

  • Suggesting targeted drug use and clinical trial information.


Chemotherapy

  • Suggesting the efficacy and side effects of chemotherapy drugs for gastrointestinal tumors.


Hereditary-related genes

  • Detect germline variant information, including Lynch syndrome-related genes.

  • Suggesting pathogenic and suspected pathogenic mutations.

Applicable Population of Individualized Medication Guidance for Gastrointestinal Cancer

  • Patients with advanced and newly diagnosed gastrointestinal tumors who need targeted drugs.

  • Patients with recurrent, drug-resistant gastrointestinal tumors.

  • Gastrointestinal cancer patients requiring targeted drug therapy via liquid biopsy.

Specification of Individualized Medication Guidance for Gastrointestinal Cancer

Sample typesTissue + venous blood / Paraffin section + venous blood / Pleural fluid and ascites + venous blood  / Venous blood
TAT10 days


Products
Contact with Capitalbio
Contact Information
Your Inquiries (Expandable)
Instruments
Detection Kits/Reagents
Research Services
Biochip Design & Fabrication
Diagnostic Services
86-10-69002900
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing